🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Status
Unknown
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2016-03
Trial ID
NCT02715362
Treatments Being Tested
Objective to study the safety and preliminary efficacy of intratumoral inje...
Status
Unknown
Location
The Fifth Medical Center of Chinese PLA General Hospital
Start Date
2019-01-01
Trial ID
NCT04951141
Treatments Being Tested
This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07523529
The purpose of this study is to determine whether autologous T cells bearin...
Status
Completed
Location
Shanghai Cancer Institute
Start Date
2015-03
Trial ID
NCT02395250
Treatments Being Tested
A Single-arm, Open-label, Multicenter, Phase Ib Clinical Trial to Evaluate ...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2023-10-08
Trial ID
NCT06560827
Treatments Being Tested
The purpose of this study is to observe and confirm the safety, tolerance a...
Status
Unknown
Location
Shanghai Chest Hospital,Shanghai Jiaotong University
Start Date
2016-03
Trial ID
NCT02876978
Treatments Being Tested
A phase I clinical study of 4th generation chimeric antigen receptor T Cell...
Status
Recruiting
Location
First Affiliated Hospital, Medical College of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT06461624
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and efficacy of a...
Status
Unknown
Location
Department of Oncology, Xinqiao Hospital
Start Date
2017-06-01
Trial ID
NCT03084380
The second generation of mesothelin targeted CAR-T cells that secret a fusi...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2023-03-10
Trial ID
NCT05779917
Treatments Being Tested
This phase I trial studies the side effects and best dose of RPCAR01 chimer...
Status
Suspended
Location
Roswell Park Cancer Institute
Start Date
2026-07-15
Trial ID
NCT06968195